Literature DB >> 21802410

Differential PAX3 functions in normal skin melanocytes and melanoma cells.

Sandra Medic1, Helen Rizos, Mel Ziman.   

Abstract

The PAX3 transcription factor is the key regulator of melanocyte development during embryogenesis and is also frequently found in melanoma cells. While PAX3 is known to regulate melanocyte differentiation, survival, proliferation and migration during development, it is not clear if its function is maintained in adult melanocytes and melanoma cells. To clarify this we have assessed which genes are targeted by PAX3 in these cells. We show here that similar to its roles in development, PAX3 regulates complex differentiation networks in both melanoma cells and melanocytes, in order to maintain cells as "stem" cell-like (via NES and SOX9). We show also that mediators of migration (MCAM and CSPG4) are common to both cell types but more so in melanoma cells. By contrast, PAX3-mediated regulation of melanoma cell proliferation (through TPD52) and survival (via BCL2L1 and PTEN) differs from that in melanocytes. These results suggest that by controlling cell proliferation, survival and migration as well as maintaining a less differentiated "stem" cell like phenotype, PAX3 may contribute to melanoma development and progression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802410     DOI: 10.1016/j.bbrc.2011.07.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Authors:  Matthew A Price; Leah E Colvin Wanshura; Jianbo Yang; Jennifer Carlson; Bo Xiang; Guiyuan Li; Soldano Ferrone; Arkadiusz Z Dudek; Eva A Turley; James B McCarthy
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

2.  Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.

Authors:  Xiaoke Wang; Krista L Bledsoe; Rondell P Graham; Yan W Asmann; David S Viswanatha; Jean E Lewis; Jason T Lewis; Margaret M Chou; Michael J Yaszemski; Jin Jen; Jennifer J Westendorf; André M Oliveira
Journal:  Nat Genet       Date:  2014-05-25       Impact factor: 38.330

3.  Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.

Authors:  Nathaniel B Goldstein; Maranke I Koster; Laura G Hoaglin; Nicole S Spoelstra; Katerina J Kechris; Steven E Robinson; William A Robinson; Dennis R Roop; David A Norris; Stanca A Birlea
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

4.  Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Authors:  Irina Berlin; Laurence Denat; Anne-Lise Steunou; Isabel Puig; Delphine Champeval; Sophie Colombo; Karen Roberts; Elise Bonvin; Yveline Bourgeois; Irwin Davidson; Véronique Delmas; Laurence Nieto; Colin R Goding; Lionel Larue
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

5.  Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.

Authors:  Jonathan G Bonchak; Jonathan M Eby; Kristin A Willenborg; David Chrobak; Steven W Henning; Anna Krzywiec; Steven L Johnson; I Caroline Le Poole
Journal:  Arch Biochem Biophys       Date:  2014-08-14       Impact factor: 4.013

6.  Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.

Authors:  A L Reid; M Millward; R Pearce; M Lee; M H Frank; A Ireland; L Monshizadeh; T Rai; P Heenan; S Medic; P Kumarasinghe; M Ziman
Journal:  Br J Dermatol       Date:  2012-11-15       Impact factor: 9.302

7.  Non-thermal atmospheric pressure plasmas as a novel candidate for preventive therapy of melanoma.

Authors:  Yasuhiro Omata; Machiko Iida; Ichiro Yajima; Kozue Takeda; Nobutaka Ohgami; Masaru Hori; Masashi Kato
Journal:  Environ Health Prev Med       Date:  2014-07-19       Impact factor: 3.674

8.  A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.

Authors:  Elise Bonvin; Paola Falletta; Heather Shaw; Veronique Delmas; Colin R Goding
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

9.  Early de novo DNA methylation and prolonged demethylation in the muscle lineage.

Authors:  Koji Tsumagari; Carl Baribault; Jolyon Terragni; Katherine E Varley; Jason Gertz; Sirharsa Pradhan; Melody Badoo; Charlene M Crain; Lingyun Song; Gregory E Crawford; Richard M Myers; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenetics       Date:  2013-02-15       Impact factor: 4.528

10.  RACK1, a clue to the diagnosis of cutaneous melanomas in horses.

Authors:  Cécile Campagne; Sophia Julé; Florence Bernex; Mercedes Estrada; Geneviève Aubin-Houzelstein; Jean-Jacques Panthier; Giorgia Egidy
Journal:  BMC Vet Res       Date:  2012-06-29       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.